Intravenous Therapies

There is an easy and safe method to avoid the nutrient deficiencies brought on by absorption problems and energy deficits associated with aging and illness, and that method is parenteral (IV) micronutrient therapy.

At IMI we tailor make our IV preparation to the needs of each patient. We recognize that every patient’s history, metabolic process and lifestyle are uniquely different; we believe that there is no single formula that works well for all patients.


The choice of what products to include in an IV infusion needs to be based on three main factors:

  • A deficiency of any nutrient elicited from history, symptoms, or testing
  • Necessary cofactors to ensure proper metabolism and action of a product
  • The known action of a nutrient or product on a disease process

Rejuvenate with Safe & Easy IV Therapy

We believe that micronutrient therapy can be life transforming. But why do we offer an infusion of vitamins, minerals, or other beneficial substances when they could prescribe the same combination via an oral route? We do this because we know that when a person becomes ill, he or she does not have the same energy as when they were well and healthy. Absorption and transport of nutrients takes energy. As people age, the ability to absorb nutrients decreases, and this is due to a gradual decrease in the secretion of gastric hydrochloric acid and, in turn, pancreatic enzymes needed to break down food or supplements so that intestinal absorption can occur.

Parenteral micronutrient therapy, or IV micronutrient therapy, as it is commonly known, has a long safety record. The relative absence of adverse reactions is due to the fact that the infused substances are naturally occurring – that is, they are essential nutrients required for the optimal functioning of the human body.

The molecules are relatively simple and thus have low potential for hypersensitivity. Getting the nutrient into the target cell is more assured, because it is delivered directly into the body’s circulation. A high-concentration gradient can be achieved, and osmotic mechanisms can act in concert with energy requiring transport.

Types of IV Therapy Offered

IV Phospho-Lipid Therapy (PK PROTOCOL)

Toxins such as pesticides, petrochemicals, preservatives in food and skincare products, molds and heavy metals can be stored in fatty tissue in the body for a long time where they interfere with functioning of the cells, often in the nervous, brain and immune systems. The human brain is made up of 60% lipids. The main route of detoxification is via the liver into bile and then into the intestines.

IV Micronutrient Vitamin Therapy

In higher, therapeutic doses given by injection, your intracellular levels of vitamins and minerals are increased and act beneficially, therapeutically in the body. This IV treatment is helpful for patients that experience headaches, migraines, upper respiratory infections, asthma, chronic fatigue, chronic viral infections, fibromyalgia, depression, anxiety, withdrawal symptoms, and allergies, and is beneficial for athletic performance and the overall health of those living stressful lifestyles.

IV Glutathione Therapy

Glutathione is the antioxidant that is present in every cell in the human body. Glutathione is primarily synthesized in the liver where it is abundantly present. A high percentage of the blood that leaves the stomach and intestines passes through the liver. The blood carries important nutrients to the liver where they are metabolized into substances vital to life. In the same way, exogenous toxic substances reach the liver where they are either activated or transformed into less toxic derivatives. Glutathione plays a crucial role in the liver’s biotransformation system.

High Dose IV Vitamin C

Vitamin C is an essential nutrient for optimal functioning of many systems in the body. It is used in the immune system, endocrine system, antioxidant enzymes, detoxification system, lipid metabolism, collagen tissue formation and absorption of iron. High Dose vitamin C has been used for many years in the oral and intravenous delivery to reverse acute and chronic disease. IMI considers vitamin C therapy to be critical for toxicity and immune deficiency syndromes.

Intravenous Vitamin C For Cancer FAQ’s

  • Research shows that intravenous vitamin C at high doses, used in conjunction with chemotherapy or radiation, kills cancer cells in the early stages of cancer. For those in the later stages of cancer, the intravenous vitamin C protocol may improve the quality of life. The protocol also suggests a strict diet with oral supplementation.

  • Each individual responds differently, and we can’t predict how different tumor types will react. A PET scan usually is a guidepost. If the PET is positive, the tumor usually responds to the vitamin C. If the PET is negative but there is an active tumor present, vitamin C is less effective in most cases. Vitamin C therapy works best in the early stages of cancer when used in conjunction with chemotherapy or radiation. It is not intended as a stand-alone treatment or as a last effort treatment for patients in the late stages of cancer.

  • No. Oral vitamin C is an antioxidant with controlled absorption. Intravenous vitamin C is a pro-oxidant drug that helps produce hydrogen peroxide, which targets neoplastic cells while leaving normal cells unharmed. Because this form is delivered intravenously, plasma and tissue levels are many times above that of oral dosing.

  • Patients must have a G6PD test before any infusions are given. We have found no contraindications to providing intravenous vitamin C with any chemotherapy when proper protocol is followed. Additions to the protocol are not recommended. The protocol should NOT be administered in conjunction with methotrexate chemotherapy because of urine pH requirements.

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited condition in which a person’s body doesn’t have enough of the G6PD enzyme. G6PD helps red blood cells function normally. Patients with this deficiency should not receive vitamin C infusions because it can cause hemolytic anemia.

  • Additions, such as B vitamins, may reduce the formation of hydrogen peroxide, which is the chemotherapeutic agent formed by intravenous vitamin C. Medical professionals administering intravenous vitamin C should follow the protocol.

  • Patients begin with a low dosage and work their way up to the therapeutic level. Once at therapeutic level, the infusions will take between 2.5-3 hours, depending on the patient’s individual saturation point, which is detailed in the protocol provided to medical professionals. We usually provide two infusions per week, but some patients may require three infusions a week. After a patient has received therapeutic-level infusions for a year, we will re-evaluate.

  • We don’t recommend stopping the intravenous vitamin C unless the patient has been cancer-free for at least a year. If the patient stops the infusions but is not cancer free, the patient may develop tumor cells that are resistant to the intravenous vitamin C’s chemotherapeutic agent. Although a patient may stop for a week if necessary, we recommend the patient receive an extra infusion the week before and the week after.

  • No. If the protocol is being followed correctly, the intravenous vitamin C is working as a chemotherapeutic agent. Just as some types of chemotherapy may not be successful, the same is true of vitamin C infusions.

  • Diet plays a huge role in the protocol. We use the four-point program: diet, oral supplements, intravenous vitamin C and chemotherapy or radiation. Oral supplements are recommended on a case by case basis. We highly recommend the book, Beating Cancer with Nutrition, by Patrick Quillin.

  • Yes, absolutely. The oxidants from cigarette smoking or second-hand smoke lower vitamin C levels in the blood. It is extremely important that patients stop smoking or limit their exposure to second-hand smoke.

  • In most cases, no.

Interested in Intravenous Therapies?

Functional medicine addresses the underlying causes of disease, using a systems oriented approach and engaging both patient and practitioner in a therapeutic partnership.